Try our beta test site
2 studies found for:    ALVINA
Show Display Options
Rank Status Study
1 Completed Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Condition: Cerebrovascular Disorders
Interventions: Dietary Supplement: Conventional diet +/- wine;   Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine
2 Completed
Has Results
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Conditions: Chronic Lymphocytic Leukemia With 17p Deletion;   Small Lymphocytic Lymphoma With 17p Deletion
Intervention: Drug: Ibrutinib

Study has passed its completion date and status has not been verified in more than two years.